286 related articles for article (PubMed ID: 32323111)
1. Two Sides of the Same Coin: The Role of Developmental pathways and pluripotency factors in normal mammary stem cells and breast cancer metastasis.
Oliphant MUJ; Kong D; Zhou H; Lewis MT; Ford HL
J Mammary Gland Biol Neoplasia; 2020 Jun; 25(2):85-102. PubMed ID: 32323111
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
Micalizzi DS; Farabaugh SM; Ford HL
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):117-34. PubMed ID: 20490631
[TBL] [Abstract][Full Text] [Related]
3. E2A Modulates Stemness, Metastasis, and Therapeutic Resistance of Breast Cancer.
López-Menéndez C; Vázquez-Naharro A; Santos V; Dubus P; Santamaría PG; Martínez-Ramírez Á; Portillo F; Moreno-Bueno G; Faraldo MM; Cano A
Cancer Res; 2021 Sep; 81(17):4529-4544. PubMed ID: 34145034
[TBL] [Abstract][Full Text] [Related]
4. Cell lineage determinants as regulators of breast cancer metastasis.
Lu W; Kang Y
Cancer Metastasis Rev; 2016 Dec; 35(4):631-644. PubMed ID: 27866304
[TBL] [Abstract][Full Text] [Related]
5. Periostin contributes to the acquisition of multipotent stem cell-like properties in human mammary epithelial cells and breast cancer cells.
Wang X; Liu J; Wang Z; Huang Y; Liu W; Zhu X; Cai Y; Fang X; Lin S; Yuan L; Ouyang G
PLoS One; 2013; 8(8):e72962. PubMed ID: 24009721
[TBL] [Abstract][Full Text] [Related]
6. GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.
Sarkar TR; Battula VL; Werden SJ; Vijay GV; Ramirez-Peña EQ; Taube JH; Chang JT; Miura N; Porter W; Sphyris N; Andreeff M; Mani SA
Oncogene; 2015 Jun; 34(23):2958-67. PubMed ID: 25109336
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between breast cancer stem cells and metastatic niche: emerging molecular metastasis pathway?
Fazilaty H; Gardaneh M; Bahrami T; Salmaninejad A; Behnam B
Tumour Biol; 2013 Aug; 34(4):2019-30. PubMed ID: 23686802
[TBL] [Abstract][Full Text] [Related]
9. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.
Farabaugh SM; Micalizzi DS; Jedlicka P; Zhao R; Ford HL
Oncogene; 2012 Feb; 31(5):552-62. PubMed ID: 21706047
[TBL] [Abstract][Full Text] [Related]
10. Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance.
Mehta GA; Khanna P; Gatza ML
J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):213-230. PubMed ID: 31069617
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition in breast cancer progression and metastasis.
Wang Y; Zhou BP
Chin J Cancer; 2011 Sep; 30(9):603-11. PubMed ID: 21880181
[TBL] [Abstract][Full Text] [Related]
12. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
[TBL] [Abstract][Full Text] [Related]
13. Pluripotency Genes and Their Functions in the Normal and Aberrant Breast and Brain.
Seymour T; Twigger AJ; Kakulas F
Int J Mol Sci; 2015 Nov; 16(11):27288-301. PubMed ID: 26580604
[TBL] [Abstract][Full Text] [Related]
14. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor 1 and breast cancer metastasis.
Liu ZJ; Semenza GL; Zhang HF
J Zhejiang Univ Sci B; 2015 Jan; 16(1):32-43. PubMed ID: 25559953
[TBL] [Abstract][Full Text] [Related]
16. Methodology to analyze gene expression patterns of early mammary development in pig models.
Moss MA; Williams B; Ferdous F; Scott T; Dunn HW
Mol Biol Rep; 2020 Apr; 47(4):3241-3248. PubMed ID: 32219771
[TBL] [Abstract][Full Text] [Related]
17. Fluid flow exposure promotes epithelial-to-mesenchymal transition and adhesion of breast cancer cells to endothelial cells.
Fuh KF; Shepherd RD; Withell JS; Kooistra BK; Rinker KD
Breast Cancer Res; 2021 Oct; 23(1):97. PubMed ID: 34641959
[TBL] [Abstract][Full Text] [Related]
18. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.
Yue Z; Yuan Z; Zeng L; Wang Y; Lai L; Li J; Sun P; Xue X; Qi J; Yang Z; Zheng Y; Fang Y; Li D; Siwko S; Li Y; Luo J; Liu M
FASEB J; 2018 May; 32(5):2422-2437. PubMed ID: 29269400
[TBL] [Abstract][Full Text] [Related]
19. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
20. OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer.
Li Y; Li L; Qin J; Wu J; Dai X; Xu J
Oncogene; 2021 Jan; 40(1):68-84. PubMed ID: 33051597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]